Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06334354 · ClinicalTrials.gov registry record
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
A clinical trial of Breast Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 420
- Enrollment target
- 7
- Study locations
NCT06334354: Recruiting study of Breast Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
NCT06334354 is a study of Breast Cancer Survivors that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 420 participants, below the 2,709-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (84% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06334354, a study of Breast Cancer Survivors, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 420 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to look at how differences in cognitive (mental) function develop over time in breast cancer survivors compared to volunteers without a history of cancer (healthy volunteers). Both cancer survivors and healthy volunteers (who are the same age as the cancer survivors) will participate in this study so the researchers can compare the results of neurocognitive testing (which looks at memory, attention, and information processing) on each group of participants.
Primary Outcome
of remote cancer diagnosis and treatment and potential association with increased/accelerated deficit accumulation in older survivors.The primary outcome is cognitive performance, as measured by CogSuite aggregate intra-individual variability, the average intra-individual variability across the subtests. Cognition will be assessed using the CogSuite battery of five subtests: 1) Attention Network Test; 2) Mental Rotation; 3) Stop Signal Delay; 4) N-back; and 5) Psychomotor Speed measures.
Conditions Studied
Interventions
- OTHER Assessments
- OTHER Assessment (Survivors Only)
- OTHER APOE and DNA Isolation
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (All Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities) - Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2028-08-31 |
What NCT06334354 shows while recruiting
NCT06334354 is an observational study that tracks outcomes without assigning an intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 2,709-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Breast Cancer Survivors appearing as the primary indexed condition, and to 3 interventions - of which Assessments is the first listed.
NCT06334354 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT06334354 about?
NCT06334354 is a clinical study titled "A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)". The purpose of this study is to look at how differences in cognitive (mental) function develop over time in breast cancer survivors compared to volunteers without a history of cancer (healthy volunteers). Both cancer survivors and healthy volunteers (who are the same age as the cancer survivors) wil...
What is the current status of trial NCT06334354?
This trial is currently recruiting. The enrollment target is 420 participants. The study started on 2024-05-10. Estimated completion is 2028-08-31.
What conditions does trial NCT06334354 study?
This clinical trial studies the following conditions: Breast Cancer Survivors.
What interventions are being tested in trial NCT06334354?
The interventions under investigation include: Assessments (OTHER), Assessment (Survivors Only) (OTHER), APOE and DNA Isolation (OTHER).
Who is sponsoring clinical trial NCT06334354?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06334354 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Survivors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06334354's enrollment target sits among peer trials
420 4th of 8 higher than 5 of 8 other Breast Cancer Survivors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Survivors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rowing Following Breast Cancer Chemotherapy
RECRUITING · NA
-
UCF MammoChat: Image Repository
RECRUITING
-
Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship
ACTIVE NOT RECRUITING
-
Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History
ACTIVE NOT RECRUITING
-
Improving Cognition After Cancer
ACTIVE NOT RECRUITING · NA
-
Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI